PHOTO-ATROP · Photochemical organocatalytic atropselective processes for the sustainable synthesis of biorelevant axially chiral molecules
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2022-11-01 → 2024-10-31
- Финансиране от ЕС
- 186 720 €
- Участници
- 2
- Схема
- HORIZON-TMA-MSCA-PF-EF
Линиите свързват координатора с партньорите.
Накратко на български
Фотохимичните процеси се използват за създаване на специфични пространствени структури в молекули, като например биарилни феноли. Това помага за по-ефективното и екологично синтезиране на биологично активни съединения и лекарства.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Photochemical organocatalytic atropselective processes for the sustainable synthesis of biorelevant axially chiral molecules
In recent years, enantioselective catalysis has become a critical tool in the synthesis of chiral molecules, particularly in drug development and the production of biologically significant compounds. While most enantioselective processes focus on sp3-hybridized stereocenters, many important natural products, drug molecules, and chiral ligands feature axial chirality, classifying them as atropisomers. Despite their significance, efficient methods for synthesizing atropisomers remain underdeveloped. The Photo-Atrop project aims to address this gap by developing a sustainable and enantioselective organo-photocatalytic strategy for the synthesis of axially chiral molecules. Our approach leverages two complementary activation methods: photoredox catalysis and organocatalysis. These combined methods allow us to generate reactive radicals under mild conditions, enabling the selective functionalization of biaryl systems to produce atropisomers with high enantioselectivity. What sets this project apart is its use of photochemical processes to introduce radical intermediates into atropselective reactions, an area that has remained largely unexplored. We believe that by harnessing visible light to generate reactive radicals from simple phenol substrates, we can create more sustainable and efficient pathways to synthesizing atropisomers. This strategy also explores the potential for regio- and enantioselective perfluoroalkylation of biaryl phenols, a challenging transformation in traditional ground-state chemistry. The photochemical approach not only reduces the need for harsh reaction conditions but also opens up new possibilities for generating complex molecular structures that are difficult to achieve through conventional methods. The Photo-Atrop project aims to provide insights that could transform how atropisomers are synthesized, offering a sustainable and scalable solution that aligns with the growing need for environmentally friendly chemical processes. By doing so, it addresses a significant challenge in synthetic chemistry, with potential implications for pharmaceuticals, materials science, and other industries that rely on chiral molecules.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Chiral molecules containing axes of chirality (known as atropisomers) are present in natural products, bioactive molecules, and functional materials. Their increasingly important role in pharmaceuticals means that effective asymmetric strategies are needed for their preparation. However, the available catalytic methods rely on ionic pathways, which limits the diversity of atropisomers that can be achieved. This project seeks to close this gap in asymmetric methodology by providing new catalytic techniques for atropselective synthesis, based on radical chemistry, to greatly boost the impact of axially chiral compounds in drug discovery. We aim to develop methods that combine enantioselective organocatalysis with visible light photochemistry, two powerful strategies with extraordinary potential for the sustainable preparation of chiral molecules. Achieving this target would also address the key synthetic challenge of developing light-driven atropselective processes proceeding via radical pathways. The research will combine the hosts expertise in photochemistry and radical reactions with the applicants background in asymmetric organocatalysis. The resulting strategies will be used as a platform for assembling libraries of atropisomeric compounds that, together with biological screening carried out in collaboration with the pharmaceutical company Bayer AG, will increase the probability of success in identifying drug-candidate structures. The PHOTO-ATROP project is unique because it provides training in organocatalysis and photochemistry applied to drug discovery, thus contributing to European excellence and sustainability. Its multicultural nature will broaden the fellows competencies and place him in a competitive position for his next career move
Оригинален текст от CORDIS (на английски).
Участници
Връзки
- Виж в CORDIS
- DOI: 10.3030/101062360
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e512972d4b&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e515669ed5&appId=PPGMS
Данни: CORDIS, © Европейски съюз
